NOVEMBER 2022LIFE SCIENCES REVIEW5Shola Oyewole, CIO, United Therapeutics Corporation [NASDAQ:UTHR]Advanced Therapies for Patients Suffering from PAHCXO INSIGHTSLAST WORD19242628Paul R. Whitacre, PMP, Associate Director, Digital Excellence, Commercial Strategy & Operations Astellas Pharma US, Inc.Hua Gong, M.D., Ph.D., SVP, Global Head of Translational Medicine and Clinical Biomarker,Zai LabDan O'Connor, VP Drug Discovery, Western Markets, Molecular DevicesThe World of Omnichannel Comes to Life Sciences: What Digital Transformation Looks Like in the Pharma IndustryAccelerating drug development of novel targeted therapies through histology-agnostic oncology clinical trialsMOLECULAR DEVICES CHALLENGES AND TRENDS IN THE SYTHETIC BIOLOGY SPACEIN MY OPINION08Cloud Computing for Affordable MedicinesManoj Shah, VP, IT and Business Support, Amneal Pharmaceuticals (NYSE: AMRX)30Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, Ferring Pharmaceuticals and Yong Yue, Senior Director, Computational Biology and Data Sciences, Ferring PharmaceuticalsChallenges And Opportunities For AI In Drug Discovery
< Page 4 | Page 6 >